Correction: Comprehensive genomic profiling of ESR1, PIK3CA, AKT1, and PTEN in HR(+)HER2(−) metastatic breast cancer: prevalence along treatment course and predictive value for endocrine therapy resistance in real-world practice.

Autor: Bhave, Manali A., Quintanilha, Julia C. F., Tukachinsky, Hanna, Li, Gerald, Scott, Takara, Ross, Jeffrey S., Pasquina, Lincoln, Huang, Richard S. P., McArthur, Heather, Levy, Mia A., Graf, Ryon P., Kalinsky, Kevin
Zdroj: Breast Cancer Research & Treatment; Oct2024, Vol. 207 Issue 3, p611-614, 4p
Databáze: Complementary Index
Externí odkaz: